4''-(acetylethylamino)-3''-tert-butyl-4'-(3-cyclopropylaminopropyl)-[1,1';3',1'']terphenyl-4-carboxylic acid

ID: ALA3954703

PubChem CID: 11663505

Max Phase: Preclinical

Molecular Formula: C33H40N2O3

Molecular Weight: 512.69

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(C(C)=O)c1ccc(-c2cc(-c3ccc(C(=O)O)cc3)ccc2CCCNC2CC2)cc1C(C)(C)C

Standard InChI:  InChI=1S/C33H40N2O3/c1-6-35(22(2)36)31-18-15-27(21-30(31)33(3,4)5)29-20-26(23-9-12-25(13-10-23)32(37)38)14-11-24(29)8-7-19-34-28-16-17-28/h9-15,18,20-21,28,34H,6-8,16-17,19H2,1-5H3,(H,37,38)

Standard InChI Key:  FPOHPLBFFPXIPO-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
   27.1857  -15.4573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8591  -15.8674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5891  -15.4567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5686  -14.6273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8681  -14.2156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1652  -14.6279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2986  -14.2165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2781  -13.3913    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.0006  -14.6010    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.4557  -15.8680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7552  -15.4564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0523  -15.8686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0457  -16.6965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7462  -17.1081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4762  -16.6975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3156  -17.1072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3361  -17.9325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6061  -18.3473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6266  -19.1726    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.8966  -19.5833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0942  -19.6094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5106  -20.3124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3247  -15.4554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6162  -15.8948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8927  -15.4817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8952  -14.6579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5981  -14.2416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3272  -14.6276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1676  -14.2406    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4647  -14.6570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7370  -14.2439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1742  -13.4169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8771  -13.0046    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.4722  -13.0324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1856  -15.8939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1895  -16.7127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4786  -15.4845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4786  -16.3033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  2  0
  4  7  1  0
  7  8  2  0
  7  9  1  0
  1 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 10 15  2  0
 13 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 20 22  1  0
 12 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 23 28  2  0
 26 29  1  0
 29 30  1  0
 30 31  1  0
 29 32  1  0
 32 33  2  0
 32 34  1  0
 25 35  1  0
 35 36  1  0
 35 37  1  0
 35 38  1  0
M  END

Associated Targets(Human)

RARA Tclin Retinoic acid receptor alpha (1324 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARB Tclin Retinoic acid receptor beta (1232 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARG Tclin Retinoic acid receptor gamma (1154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 512.69Molecular Weight (Monoisotopic): 512.3039AlogP: 7.07#Rotatable Bonds: 10
Polar Surface Area: 69.64Molecular Species: ZWITTERIONHBA: 3HBD: 2
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.07CX Basic pKa: 10.00CX LogP: 4.21CX LogD: 4.21
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.29Np Likeness Score: -0.33

References

1.  (2008)  Novel ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof, 
2. Zhang, L L and 7 more authors.  1996-07-05  Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.  [PMID:8709094]
3. Canan Koch, S S SS and 6 more authors.  1999-02-25  Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells.  [PMID:10052980]
4. Haffner, Curt D CD and 13 more authors.  2004-04-08  Structure-based design of potent retinoid X receptor alpha agonists.  [PMID:15056000]
5. Patch, Raymond J RJ and 16 more authors.  2011-02-10  Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents.  [PMID:21218783]
6. Gege, Christian C, Schlüter, Thomas T and Hoffmann, Thomas T.  2014-11-15  Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.  [PMID:25305688]
7. Haffez, Hesham and 7 more authors.  2018-05-01  Probing biological activity through structural modelling of ligand-receptor interactions of 2,4-disubstituted thiazole retinoids.  [PMID:29439915]

Source